The firm recently hired Kathy Ordoñez as chief commercial officer, who plans to develop clinical opportunities for the company.
The company's product revenues increased over the prior year period, although total revenues missed analysts' average forecast.
The firms will combine PacBio's single-molecule sequence data and de novo assembly with Bluebee's cloud-based genomics analysis platform.
In 2015, the iBOL project met its initial milestone of generating barcode sequences for 500,000 animal, plant, and fungal species.
In its suit PacBio alleges that Oxford Nanopore infringes two patents it holds related to nanopore sequencing.
PacBio is refining the CRISPR/Cas9 capture technique with several early- access sites and plans to launch it more broadly in 2018.
The nanopore ZMW can enable lower starting amounts of DNA for PacBio sequencing, and may eventually enable direct RNA sequencing.
The Index gained 4 percent, outperforming the Dow and the Nasdaq, but underperformed the Nasdaq Biotechnology Index, which rose 5 percent.
PacBio has released new software, which has increased read lengths and throughput, and aims to launch a new sample prep protocol and chemistry this year.
Although PacBio's product and services revenues were up 17 percent, total revenues declined 3 percent due to a lack of contractual revenue in the quarter.
Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.
US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.
Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.
In Science this week: almond reference genome, and more.